GlassScriptPhysician profile
Kamran A Rizvi
NPI 1104002484
$11,208.40
in general payments reported to CMS, 2019-2025
34 companies · $535 in 2025
The $535 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,225 · 2020: $1,790 · 2021: $2,699 · 2022: $1,125 · 2023: $2,434 · 2024: $399 · 2025: $535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,875 · Food and Beverage: $1,494.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,875.00 |
| Food and Beverage | $1,493.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $7,142.24 | 2019-2025 | Accent, Jot Dx, Thoratec Heartmate 3 Lvas Implant Kit |
| Novartis Pharmaceuticals Corporation | $573.10 | 2019-2024 | |
| Pfizer INC. | $511.17 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $364.82 | 2020-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $335.79 | 2019-2022 | |
| Edwards Lifesciences Corporation | $258.84 | 2019-2022 | |
| Atricure, INC. | $208.75 | 2021 | |
| Sanofi-Aventis U.S. LLC | $206.98 | 2019-2022 | |
| Medtronic, INC. | $160.15 | 2022-2024 | Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan, Mycarelink |
| Amgen INC. | $157.14 | 2019-2022 | |
| Lundbeck LLC | $131.18 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $116.07 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $114.30 | 2019-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $96.15 | 2020-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $93.65 | 2021-2024 | Verquvo |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $91.93 | 2019-2020 | |
| Philips North America LLC | $79.51 | 2020-2024 | (Ck4) Mcot |
| Biosense Webster, INC. | $76.61 | 2019-2020 | |
| Alnylam Pharmaceuticals INC. | $73.11 | 2022 | |
| Vital Connect, INC | $65.79 | 2023-2025 | Vitalpatch Rtm |
| Elutia, INC. | $54.08 | 2019-2022 | |
| Abiomed | $48.42 | 2019-2023 | Impella |
| Stryker Corporation | $34.24 | 2025 | Flowtriever |
| Cordis US Corp. | $32.19 | 2024 | Mynx Control |
| Boston Scientific Corporation | $25.95 | 2025 | Latitude Communicator Power Supply |
| G Medical Diagnostic Services, INC. | $25.58 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $24.98 | 2023 | Inpefa |
| Esperion Therapeutics, INC. | $20.08 | 2020 | |
| Ethicon US, LLC | $17.74 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $16.54 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $15.40 | 2023 | Arcalyst |
| Angiodynamics, INC. | $14.45 | 2022 | |
| Irhythm Technologies, INC. | $11.47 | 2019 | |
| Bardy Diagnostics, INC. | $10.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kamran Rizvi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.